Dose-Escalated Radiation Therapy as Primary Treatment for Residual Bladder Cancer After Transurethral Resection.

Adv Radiat Oncol · 2024 · PMC10801638 · PMID 38260237

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

showed a trendP = .059so close (0.05 < p ≤ 0.1)

Overall survival also showed a trend favoring the dose-escalation group (54.9% vs 36.2%; P = .059).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.